Oxford Nanopore Technologies
Begbroke Science Park
Sandy Lane
Kidlington
OX5 1PF
United Kingdom
Tel: 44-0-870-486-1966
Fax: 44-0-1865-854-830
Website: http://www.nanoporetech.com/
62 articles about Oxford Nanopore Technologies
-
ONT Chosen for Comprehensive Human Genome Program
5/13/2022
Oxford Nanopore sequencing technology is to be used by a group of researchers led by Evan Eichler, University of Washington and Danny Miller, University of Washington and Seattle Children's Hospital, to initially sequence 500 of the 1000 Genomes Project samples.
-
Genomics England Expands Nanopore Use in Cancer
4/4/2022
Oxford Nanopore has announced the next steps in its collaboration with Genomics England, which is using nanopore technology in an ongoing proof-of-concept project to evaluate the clinical and research applications of comprehensive genomic analysis of cancer tumours.
-
ONT Shows New High-Accuracy, High-Output Chemistry
3/30/2022
Nanopore sequencing enables the analysis of native DNA/RNA and sequencing of any length fragment from short to ultra-long, enabling the elucidation of all types of genetic and epigenetic variants.
-
Oxford Nanopore Technologies PLC Announces Nanopore Sequencing Profiles TB: Find Evaluation
3/24/2022
Oxford Nanopore announces positive evaluation of new method for rapid drug-resistant tuberculosis profiling
-
Oxford Nanopore Releases Short Fragment Mode
3/23/2022
Short Fragment Mode will be integrated into the operating software that drives nanopore devices, allowing sequencing of fragments as short as 20 bases on nanopore platforms.
-
Oxford Nanopore Technologies plc Announces Publication: Nanopore IDs >50 Genetic Diseases
3/8/2022
A new DNA sequencing based test method developed by a team led by Ira Deveson, Head of Genomics Technologies at the Garvan Institute of Medical Research and collaborators, has been shown to screen for more than 50 genetic neurological and neuromuscular diseases.
-
Fastest Human Genome Sequence Uses Oxford Nanopore
1/13/2022
Traditionally, rapid characterisation of variants that cause genetic disease, from whole human genome sequencing, has been challenging.
-
Oxford Nanopore Announces Technology Updates - Dec 02, 2021
12/2/2021
Highlights include release of new "Kit 12" and R10.4 flow cells for >Q20 raw read and around Q30 Duplex sequencing accuracy, and the new PromethION P2 device, a palm-sized, high-throughput sequencer that delivers the most accessible low-cost, high-output Oxford Nanopore sequencer
-
Oxford Nanopore announces multiple releases, for high-accuracy, content-rich, high-throughput whole-genome sequencing, and dynamic targeted sequencing
10/28/2020
Oxford Nanopore announces multiple releases that expand and improve its sequencing technology offering in human genomics, at ASHG 2020.
-
LamPORE test for SARS-CoV-2 detection gains CE-IVD mark
10/9/2020
LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19.
-
New study stacks up Loop Genomics, PacBio and Oxford Nanopore long read sequencing
7/29/2020
A new pre-print runs a head-to-head comparison between Loop Genomics, PacBio and Oxford Nanopore's accuracy in long read microbiome sequencing.
-
Jury Invalidates PacBio's Patents in U.S. Patent Trial Against Oxford Nanopore
3/18/2020
After more than one week of evidence, a federal jury in Delaware found in favour of Oxford Nanopore and invalidated all four patents asserted by Pacific Biosciences in this litigation.
-
Oxford Nanopore Announces That It Has Entered Into a Non-exclusive Agreement With Caribou Biosciences for CRISPR-Cas9 Enrichment for Nanopore Sequencing
9/19/2019
Technology enables targeted sequencing for rapid, precise DNA analysis on portable or large sequencers
-
Oxford Nanopore Launches Flongle for Rapid, Smaller DNA/RNA Sequencing Tests in Any Environment
3/12/2019
Oxford Nanopore has made Flongle starter packs available to purchase https://store.nanoporetech.com/flongle.html, after initial testing in an early-access programme.
-
RNA sequencing transformed: Oxford Nanopore introduces new cDNA Sequencing Kits
2/4/2019
New generation direct cDNA and PCR-cDNA 109 Kits provide full-length cDNA transcripts at high yields.
-
Amgen Invests £50 Million ($66 Million) In Oxford Nanopore Technologies
10/18/2018
Amgen (NASDAQ:AMGN) and Oxford Nanopore Technologies today announced Amgen's equity investment of £50 million ($66 million) in Oxford Nanopore, a privately-owned, UK-based company advancing a new generation of portable, real-time genetic sequencing technology.
-
Oxford Nanopore Launches MinIT, a Powerful Analysis Device to Enable Real Time, Portable DNA Sequencing
10/10/2018
MinIT is now arriving with genomics researchers.
-
Oxford Nanopore Announces £100 Million ($140M) Fundraising from Global Investors
3/20/2018
Oxford Nanopore Technologies Ltd has raised £100M ($140M) in new investment.
-
WuXi NextCODE Integrates Oxford Nanopore into the Global Platform for Genomic Data
10/18/2017
WuXi NextCODE today announced the first open-access installation of Oxford Nanopore instruments in a CAP/CLIA lab in China at WuXi NextCODE's sequencing laboratory in Shanghai.
-
PAGXXV Genomic Sequencing: New Machines, New Era for Illumina, Pacific Biosciences and Oxford Nanopore
1/23/2017